bioRxivImmunology
Epigenetic alterations underlie airway macrophage differentiation and phenotype during lung fibrosis
P. McErlean, C. G. Bell, R. J. Hewitt, Z. Busharat, P. P. Ogger, P. Ghai, G. Albers, S. Kingston, P. Molyneaux, S. Beck, C. M. Lloyd, T. M. Maher, A. J. Byrne
Abstract
Airway macrophages (AMs) are key regulators of the lung environment and are implicated in the pathogenesis of idiopathic pulmonary fibrosis (IPF), a fatal respiratory disease with no cure. However, the epigenetics of AMs development and function in IPF are limited. Here, we characterised the DNA-methylation (DNAm) profile of AMs from IPF (n=30) and healthy (n=14) donors. Our analysis revealed epigenetic heterogeneity was a key characteristic of IPF AMs. DNAm clock analysis indicated epigenetic alterations in IPF-AMs was not associated with accelerated ageing. In differential DNAm analysis, we identified numerous differentially methylated positions (DMPs, n=11) and regions (DMRs, n=49) between healthy and IPF AMs respectively. DMPs and DMRs encompassed genes involved in lipid (LPCAT1) and glucose (PFKB3) metabolism and importantly, DNAm status was associated with disease severity in IPF. Collectively, our data identify that profound changes in the epigenome underpin the development and function of AMs in the IPF lung.
- organism: human
- assay: DNA methylation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- IPF distal lung epithelial cells acquire a DNA methylation signature consistent with activation of basal cell transcriptional programs
Arlo C. Colvard, Stefano A. Iantorno, … Jason J. Gokey·bioRxiv·Sep 22, 2026
- Epigenetic de-repression of basal cell metaplasia in aging AT2 cells is a risk factor for idiopathic pulmonary fibrosis (IPF).
Stefano A. Iantorno, Ying Wei, … Claude Jourdan Le Saux·bioRxiv·Jun 10, 2026
- Alveolar epithelial cell plasticity and injury memory in human pulmonary fibrosis
Taylor Sterling Adams, Jonas C. Schupp, … Naftali Kaminski·bioRxiv·Jun 10, 2025
- Integrated multiomic analysis identifies TRIP13 as a mediator of alveolar epithelial type II cell dysfunction in idiopathic pulmonary fibrosis
Laurence St. Pierre, Asres Berhan, … Zea Borok·bioRxiv·Apr 5, 2024
- Pharmacological Inhibition of Epac1 Protects against Pulmonary Fibrosis by Blocking FoxO3a Neddylation
Katherine Jankowski, Sarah-Eve S Lemay, … Lahouaria Hadri·European Respiratory JournalPeer-reviewed·Jul 10, 2025
- Type-1 IFN primed monocytes in pathogenesis of idiopathic pulmonary fibrosis
L.-P. Ho, E. Fraser, … J. Rehwinkel·bioRxiv·Jan 16, 2020